Issue 1376: July 25, 2018


TOP STORIES


IAC HANDOUTS


WORLD NEWS


FEATURED RESOURCES


EDUCATION AND TRAINING


CONFERENCES AND MEETINGS

 


TOP STORIES


CDC updates recommendations in its “General Best Practice Guidelines for Immunization”

CDC has recently updated its General Best Practice Guidelines for Immunization with several changes. The page numbers correspond to the version in the PDF format.

  • Page 36 (Table 3-4): The dosages for Hepatitis A IG have changed under timing and spacing of immunobiologics 
  • Page 52 (Table 4-1): Three precautions have been removed from the DTaP row under contraindications and precautions. These precautions include collapse or shock-like state (i.e., hypotonic hyporesponsive episode) within 48 hours after receiving a previous dose of DTP/DTaP; seizure ≤3 days after receiving a previous dose of DTP/DTaP; and persistent, inconsolable crying lasting ≥3 hours within 48 hours after receiving a previous dose of DTP/DTaP.
  • Page 56 (Table 4-1): “Use of aspirin or aspirin-containing products” has been removed from the varicella row under contraindications and precautions. This recommendation is now harmonized with the adult schedule and includes an accompanying footnote that explains the circumstances behind waiting for 6 weeks after varicella vaccine to receive aspirin or aspirin-containing products. 
  • Page 59 (Table 4-2): A header under contraindications and precautions has been changed to "Conditions incorrectly perceived as contraindications or precautions to vaccination”
  • Page 94, subheading “Multiple Vaccinations”: Hep A vaccine and IG have been added to the pairs which should not be administered in the same limb under vaccine administration
  • Page 99 (Table 6-1): A new volume "0.5 cc" was added under the RZV row in the vaccine administration section, along with a footnote that states that only 0.5 cc should be withdrawn even if more vaccine remains in the vial

CDC's new List of Errata/Updates web page provides a list of errata and updates that have been made to General Best Practice Guidelines for Immunization: Best Practices Guidance of ACIP. The list is updated whenever it is determined changes are necessary.

Related Links

Back to top


August is National Immunization Awareness Month; first week will focus on getting ready for back to school 

Every year in August, National Immunization Awareness Month (NIAM) provides an opportunity to raise awareness of the importance of immunization and the need for improving national vaccination coverage levels. NIAM is co-sponsored by the National Public Health Information Coalition (NPHIC) and CDC.

The 2018 edition of the communications toolkit, put out by NPHIC in collaboration with CDC, contains key messages, vaccine information, sample news releases and articles, sample social media messages, links to web resources from CDC and other organizations, and logos, web banners, posters, and graphics to use with social media. The website also includes a place for you to share your NIAM activities and view what others are doing for NIAM, using the hashtag #NIAM18.



The observance features a different group each week of August: 
  • July 29–August 4—Back to School: Ready for school? Make sure those vaccine records are up to date!
  • August 5–11—Pregnant Women: Protect yourself and pass protection on to your baby 
  • August 12–18—Babies and Young Children: A healthy start begins with on-time vaccinations
  • August 19–25—Preteens & teens: Ensure a healthy future with vaccines
  • August 26–31—Adults: Vaccines are not just for kids​

Related Links

Back to top
 


IAC Spotlight! The "View All Materials" pages on IAC’s website list more than 300 IAC handouts for patients and staff, including educational materials, patient handouts, and slide sets

The "View All Materials" web pages in the Handouts section of IAC's website are the place where you can find more than 300 handouts for patients and healthcare professionals, including educational materials, patient handouts, and slide sets. Opening the "View All Materials" tab on the Handouts for Patients and Staff page allows you to sort and view the handouts by title, language, date of most recent update, item number, handouts for patients, and educational materials for staff. 

Visit the "View All Materials" pages to view them sorted:

You also have the choice of viewing all handouts for staff or all handouts for patients:

Related Link

Back to top


CDC publishes “World Hepatitis Day—July 28, 2018” in this week’s MMWR

CDC published World Hepatitis Day—July 28, 2018 in the July 20 issue of MMWR (page 773) which features a report on progress toward access to hepatitis B treatment worldwide. The first paragraph is reprinted below.

World Hepatitis Day is commemorated each year on July 28 with the goal of promoting awareness and inspiring action to prevent and treat viral hepatitis. The World Health Organization’s (WHO) theme of this year’s World Hepatitis Day is “Test. Treat. Hepatitis” to underscore the urgent need to scale up testing and treatment activities. 

Related Links

Back to top


CDC publishes "Access to Treatment for Hepatitis B Virus Infection—Worldwide, 2016" in this week's MMWR

CDC published Access to Treatment for Hepatitis B Virus Infection—Worldwide, 2016 in the July 20 issue of MMWR (page 773–7). The summary is reprinted below.

What is already known on the topic?
An estimated 257 million persons were living with chronic hepatitis B virus (HBV) infection in 2015.

What is added by this report?
Among persons living with HBV worldwide, approximately 27 million (10.5%) were aware of their infection, including 4.5 million (16.7%) who were on treatment. In 2017, all but two low- and middle-income countries could legally procure generic entecavir or tenofovir, the medicines active against HBV infection. The median price of generic tenofovir fell by >85% from 2004 to 2016. However, global treatment coverage of HBV was low.

What are the implications for public health practice?
Access to treatment could be increased by taking advantage of reductions in price of antivirals active against HBV infection.

 
View Access to Treatment for Hepatitis B Virus Infection—Worldwide, 2016 in HTML format.

Back to top


Reminder: Nominations due for HPV Vaccine Is Cancer Prevention Champion Award by August 10; CDC offers new resources to help providers promote HPV vaccination

The HPV Vaccine Is Cancer Prevention Champion Award is given annually by CDC, the American Cancer Society (ACS), and the Association of American Cancer Institutes (AACI). This award recognizes clinicians, clinics, practices, groups, and health systems that are going above and beyond to foster HPV vaccination among adolescents in their communities. This year, up to one Champion from each of the 50 U.S. states, 8 U.S. Territories and Freely Associated States, and the District of Columbia will be recognized.

State and territorial immunization program managers will coordinate the nomination and review process, and then send their nomination to CDC for final review. The 2018 award recipients will be announced in the fall of 2018. Champions will be featured on CDC’s website and in the #PreteenVaxNews e-newsletter. Champions will also receive a congratulatory letter from AACI, ACS, and CDC, an HPV Vaccine Is Cancer Prevention Champion plaque, and a digital web badge for their websites. Nominations are due by August 10.

Click on the graphic below to find out more about nominating an HPV Champion.


Back to top


IAC HANDOUTS


IAC posts 9 updated translations of its popular “Screening Checklist for Contraindications to Vaccines for Adults"

IAC recently posted 9 updated translations of its Screening Checklist for Contraindications to Vaccines for Adults. The second page of each now matches the English-language version. The first page is intended for a patient to complete, while the second page—in English—provides an explanation of why each question is asked as a reference for the patient's healthcare provider.

Access the English-language version.

Related Links

Back to top


WORLD NEWS


UNICEF and WHO report record number of infants vaccinated in 2017 and urge coordinated efforts to reach all children

UNICEF published a press release on July 16, reporting a record 123 million infants were immunized globally in 2017. Portions of the press release are reprinted below.

The data shows that:

  • 9 out of every 10 infants received at least one dose of diphtheria-tetanus-pertussis (DTP) vaccine in 2017, gaining protection against these deadly diseases.  
  • An additional 4.6 million infants were vaccinated globally with three doses of the diphtheria-tetanus-pertussis vaccine in 2017 compared to 2010, due to global population growth.
  • 167 countries included a second dose of measles vaccine as part of their routine vaccination schedule and 162 countries now use rubella vaccines. As a result, global coverage against rubella increased from 35 percent in 2010 to 52 percent.  
  • The human papillomavirus (HPV) vaccine was introduced in 80 countries to help protect women against cervical cancer. 
  • Newly available vaccines are being added as part of the life-saving vaccination package—such as those to protect against meningitis, malaria and even Ebola.

Despite these successes, almost 20 million children did not receive the benefits of full immunization in 2017. Of these, almost 8 million (40 percent) live in fragile or humanitarian settings, including countries affected by conflict. In addition, a growing share are from middle-income countries, where inequity and marginalization, particularly among the urban poor, prevent many from getting immunized. 

Related Links

Back to top


WHO publishes report from the June meeting of the Global Advisory Committee on Vaccine Safety in this week's Weekly Epidemiological Record

WHO published a report from the meeting of the Global Advisory Committee on Vaccine Safety, held on June 6–7, 2018, in the July 20 issue of its Weekly Epidemiological Record. The report is titled Global Advisory Committee on Vaccine Safety, 6–7 June 2018.

Related Link

Back to top


CDC issues travel notice on extensively drug-resistant typhoid fever in Pakistan

CDC recently posted the travel alert, Extensively Drug-Resistant Typhoid Fever in Pakistan. The ongoing outbreak involves extensively drug-resistant (XDR) typhoid fever in Pakistan that does not respond to most antibiotics. During 2018, cases have been reported in the United Kingdom and in the United States among travelers returning from Pakistan.

Find additional information on other vaccines and precautions for travelers to Pakistan on CDC's Health Information for Travelers to Pakistan, Traveler View web page.

Related Links

Back to top


CDC publishes “Notes from the Field: Widespread Transmission of Circulating Vaccine-Derived Poliovirus Identified by Environmental Surveillance and Immunization Response—Horn of Africa, 2017–2018” in this week’s MMWR

CDC published Notes from the Field: Widespread Transmission of Circulating Vaccine-Derived Poliovirus Identified by Environmental Surveillance and Immunization Response—Horn of Africa, 2017–2018 in the July 20 issue MMWR (pages 787–9). The first two paragraphs are reprinted below.

After the declaration of eradication of wild poliovirus type 2 in 2015, all countries using oral poliovirus vaccine (OPV) switched from using trivalent OPV (tOPV) (containing vaccine virus types 1, 2, and 3) to bivalent OPV (bOPV) (containing types 1 and 3) in April 2016. Vaccine-derived polioviruses (VDPVs), strains that have diverged from the live vaccine virus during prolonged circulation, can emerge rarely in areas with inadequate OPV coverage and can cause outbreaks of paralysis. Before the global switch from tOPV to bOPV, many circulating VDPV (cVDPV) outbreaks identified globally were caused by type 2 cVDPV (cVDPV2). After the switch, two large cVDPV2 outbreaks occurred in 2017 in the Democratic Republic of the Congo (continuing in 2018) and Syria.

Somalia, Kenya, and Ethiopia make up much of the Horn of Africa. Performance indicators for acute flaccid paralysis (AFP) surveillance, an indicator of the sensitivity of surveillance to detect a case of polio, indicate some subnational gaps in these countries, including in areas of Somalia that are inaccessible for polio vaccination activities. Sixteen environmental poliovirus surveillance (sewage sampling) sites have been established in these countries to supplement AFP surveillance.


Access Widespread Transmission of Circulating Vaccine-Derived Poliovirus Identified by Environmental Surveillance and Immunization Response—Horn of Africa, 2017–2018 in HTML format.

Back to top


FEATURED RESOURCES


Still available! IAC's sturdy laminated versions of the 2018 U.S. child/teen immunization schedule and the 2018 U.S. adult immunization schedule—order a supply for your healthcare setting today!

IAC's laminated versions of the 2018 U.S. child/teen immunization schedule and the 2018 U.S. adult immunization schedule are covered with a tough, washable coating; they will stand up to a year's worth of use in every area of your healthcare setting where immunizations are given. Both schedules are eight pages (i.e., four double-sided pages) and are folded to measure 8.5" x 11".

Adult Laminated Immunization Schedules

Adult Laminated Immunization Schedules

Laminated schedules are printed in color for easy reading, come complete with essential tables and footnotes, and include contraindications and precautions—a feature that will help you make an on-the-spot determination about the safety of vaccinating patients of any age.

PRICING
1–4 copies: $7.50 each
5–19 copies: $5.50 each
20–99 copies: $4.50 each
100–499 copies: $4.00 each
500–999 copies: $3.50 each

For quotes on customizing or placing orders for 1,000 copies or more, call (651) 647-9009 or email admininfo@immunize.org.

You can access specific information on both schedules, view images of both, order online, or download an order form at the Shop IAC: Laminated Schedules web page.

Back to top


IAC's 142-page book, Vaccinating Adults: A Step-by-Step Guide, describes how to implement adult vaccination services in your healthcare setting and provides a review for staff who already vaccinate adults; IAC Guide available for free download

In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide).



This completely updated guide on adult immunization (originally published in 2004) provides easy-to-use, practical information covering important “how-to” activities to help providers enhance their existing adult immunization services or introduce them into any clinical setting, including:

  • setting up for vaccination services,
  • storing and handling vaccines,
  • deciding which people should receive which vaccines,
  • administering vaccines,
  • documenting vaccinations (including legal issues), and
  • understanding financial considerations and billing information.

In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.

The entire Guide is available to download/print free of charge at www.immunize.org/guide. The downloaded version is suitable for double-sided printing. Options are available online to download the entire book or selected chapters. The development of the Guide was supported by the National Vaccine Program Office (NVPO) and the Centers for Disease Control and Prevention (CDC). Expert staff from both agencies also provided early technical review of the content.

The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!

Related Links

Back to top


EDUCATION AND TRAINING


Weekly CDC webinar series on "The Pink Book" chapter topics continues August 1 with "Rotavirus and Hepatitis A"; register now for series running through September 26
 
CDC is presenting a 15-part webinar series to provide a chapter-by-chapter overview of the 13th edition of Epidemiology and Prevention of Vaccine-Preventable Diseases (also known as "The Pink Book"). This is a live series of weekly 1-hour webinars that started June 6 and will run through September 26. The webinar series provides an overview of vaccines and the diseases they prevent, general recommendations for vaccines, vaccination principles, and immunization strategies for providers.
 
The August 1 webinar will cover "Rotavirus and Hepatitis A" and include a live Q&A session. Recordings of sessions will be available online within 2 weeks after each webinar. All sessions begin at 12:00 p.m. (ET). Continuing education will be available for each event.

Registration and more information is available on CDC's Pink Book Webinar Series web page.

All the sections of "The Pink Book" (i.e., chapters, appendices, 2017 supplement) are available to download at no charge at www.cdc.gov/vaccines/pubs/pinkbook/index.html.

You can also order a soft-cover copy of this book from the Public Health Foundation for $40 plus shipping and handling.

Back to top


CDC to host “CDC Current Issues in Immunization Webinar” on August 7, with updates for the 2018–2019 influenza season

CDC will present a one-hour Current Issues in Immunization NetConference on August 7 at 12:00 p.m. (ET). The speakers will provide healthcare professionals with an update on influenza for the 2018–2019 season. The NetConference will be moderated by Andrew Kroger, MD, MPH, medical officer, National Center for Immunization and Respiratory Diseases (NCIRD), CDC, and feature Lisa Grohskopf, MD, MPH, medical officer, Influenza Division, NCIRD, CDC, as the speaker.

This is a limited registration event. Registration is required.

Related Link

Back to top


Video presentations from the June 2018 ACIP meeting are now available online

ACIP recently posted the video presentations from the ACIP meeting held June 20–21. A summary of the recommendations approved during the meeting is reprinted below.

ACIP approved the following recommendations by majority vote at its June 2018 meeting:

  • Reaffirmed the seasonal influenza recommendations for the 2018–2019 influenza season
  • Anthrax vaccine use for post-exposure prophylaxis in a mass vaccination campaign

These recommendations have been adopted by the CDC Director and will become official once published in MMWR.

ACIP will hold its next meeting on October 24–25 in Atlanta. To attend the meeting, ACIP attendees (participants and visitors) must register online. The registration deadline for non-U.S. citizens is September 26; for U.S. citizens, it's October 10. Registration is not required to watch the meeting via webcast or listen to the proceedings via phone.

Related Links

Back to top
 


2018 Nevada Health Conference scheduled for October 15–16

The 2018 Nevada Health Conference, supported by the Nevada State Division of Public and Behavioral Health, will be held October 15–16 in Reno. This year’s theme is “Paving the Path to a Healthy Nevada.” The two-day conference offers concurrent workshop sessions and opens with keynote speaker and pediatrician, Nathan Boonstra, MD, FAAP, on day one. On day two of the conference, intensive general mini sessions provide in-depth and focused training opportunities.

Continuing education credits are available for multiple healthcare-related fields.

Related Links

Back to top
 


2018 Clinical Vaccinology Course scheduled for November 9–10

The National Foundation of Infectious Disease's (NFID) Fall 2018 Clinical Vaccinology Course will be held November 9–10 in Bethesda, MD. This 2-day course focuses on new developments and issues related to the use of vaccines. Expert faculty provide the latest information on vaccines, including updated recommendations for vaccinations across the lifespan, and innovative and practical strategies for ensuring timely and appropriate immunization. Continuing education credit is available for attendees.

The National Foundation for Infectious Diseases (NFID) invites abstract submissions of clinical best practices for poster presentation. Abstracts will be peer-reviewed for quality, originality, and overall impact. Accepted abstracts will be scheduled as poster presentations at the course. The deadline for submissions is September 10.

Related Links

Back to top

About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue.

If you have trouble receiving or displaying IAC Express messages, visit our online help section.

IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.

IAC Express Disclaimer
ISSN: 1526-1786
Our mailing address is
Immunization Action Coalition
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114

Copyright (C) 2018 Immunization Action Coalition
All rights reserved.

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .